You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 6,495,738


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,495,738
Title: Modification of fatty acid composition in plants by expression of a fungal acyl-CoA desaturase
Abstract:Genes-encoding a delta-9 CoA desaturase from Aspergillus nidulans have been isolated. The proteins encoded by genes, when expressed in a plant, can alter the saturate levels of the oil.
Inventor(s): Folkerts; Otto (Guilford, CT), Merlo; Donald J. (Carmel, IN)
Assignee: Dow AgroSciences LLC (Indianapolis, IN)
Application Number:09/280,428
Patent Claims:1. An isolated nucleic acid having a nucleotide sequence of SEQ ID NO:5 or SEQ ID NO:12.

2. An isolated nucleic acid encoding the protein of SEQ ID NO:6.

3. A DNA construct comprising, in the 5' to 3' direction: a promoter regulatory element, a nucleic acid fragment encoding a palmitoyl-CoA .DELTA.-9 desaturase from Aspergillus, and a transcriptional terminator sequence, wherein either said promoter regulatory element or said transcription termination sequence is not naturally associated with said nucleic acid fragment.

4. The construct of claim 3 wherein said promoter regulatory element is selected from the group consisting of ubiquitin promoter, maize globulin promoter, maize streak virus leader sequence, 35s promoter, 35T promoter, the first intron of maize alcohol dehydrogenase and beta-phaseolin promoter.

5. The construct of claim 3 wherein said nucleic acid fragment is selected from the group consisting of SEQ ID NO:5 and SEQ ID NO:12.

6. A plant cell stably incorporating into its genome the nucleic acid construct of claim 3.

7. A plant cell stably incorporating 4 into its genome the nucleic acid construct of claim 5.

8. A plant cell of claim 6 wherein said promoter regulatory element is selected from the group consisting of ubiquitin promoter, maize globulin promoter, maize streak virus enhancer region, 35s promoter, doubly enhanced 35s promoter, the first intron of maize alcohol dehydrogenase and beta-phaseolin.

9. A plant cell of claim 6 wherein said plant cell is selected from the group consisting of soybean, a Brassicaceae species, canola, rape, sunflower, flax, safflower, coconut, palm, olive, peanut, cotton, castor bean, coriander, a Crambe species, a Cuphea species, a Euphorbia species, a Oenothera species, jojoba, a Lesquerella species, marigold, a Limnanthes species, a Vernonia species, Sinapis alba, cocoa, tobacco, and maize.

10. A plant cell of claim 6 wherein said cell is a seed embryo cell.

11. A transgenic plant produced from a plant cell of claim 6.

12. Seed and progeny thereof which stably incorporate the nucleic acid construct of claim 4, said seed and progeny produced from a transgenic plant of claim 11.

13. A method of producing a plant oil having altered levels of fatty acids comprising: growing a plant cell having integrated into its genome a construct comprising, in the 5' to 3' direction, a promoter regulatory element functional in a plant cell; a nucleic acid fragment that encodes a delta-9 CoA desaturase isolated from Aspergillus, the delta-9 CoA desaturase selected from the group consisting of SEQ ID NO:6, SEQ ID NO:6 with conservative amino acid substitutions, and derivatives of any thereof; and a transcriptional terminator sequence.

Details for Patent 6,495,738

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2018-03-30
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2018-03-30
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2018-03-30
Aimmune Therapeutics, Inc. PALFORZIA peanut (arachis hypogaea) allergen powder Powder 125696 01/31/2020 ⤷  Try a Trial 2018-03-30
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.